Drug
Blu 945
Blu 945: highest development phase Phase 1, developed by Blueprint Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Blueprint Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BLU-945 NCT04862780 | Phase 1 | Lung Neoplasms |
Latest
No recent events.
Follow Blu 945 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.